Vertex Pharmaceuticals, Inc. (VRTX)
462.50
-3.60
(-0.77%)
USD |
NASDAQ |
Mar 17, 16:00
461.71
-0.79
(-0.17%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap : 117.49B for March 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 179.27B |
| Moderna, Inc. | 21.30B |
| Amgen, Inc. | 194.68B |
| Pfizer Inc. | 156.20B |
| Regeneron Pharmaceuticals, Inc. | 80.23B |
Market Cap Related Metrics
| PE Ratio | 30.16 |
| PS Ratio | 9.883 |
| Price to Book Value | 6.294 |
| Price to Free Cash Flow | 37.37 |
| Price | 462.50 |
| Earnings Yield | 3.32% |
| Operating PE Ratio | 25.17 |
| Normalized PE Ratio | 27.57 |